Network Insights Methodology Whitepaper Get Access

FDA

ORG Government / Drug and Medical Device Regulation Momentum 64.3ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates 20% of US consumer spending across drugs, devices, and food. Accelerated 53 novel drug approvals in 2025, including first gene therapies for sickle cell disease and expanded generic drug pathways.

0.12
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
64.3
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
48
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
White House PlocamiumAI United States HHS AstraZeneca Dr. WASHINGTON Robert F. Kennedy Jr. Eli Lilly RFK Jr. CMS China Europe Americans President
Watch This Entity
PSI Intelligence
30-Day Trend
2026-06-17 2026-07-17 51 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.640
Narrative Drift
0.000
Spectral Shift
595.316
Sentiment-Momentum Divergence
0.000
Source Concentration
0.749
Signal
FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #366 of 1207 in Government — in line with sector peers. PSI up 0.28 from yesterday (-0.16 -> 0.12).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
366 of 1207
Sector Rank
+0.24
Peer Z-Score
70%
Sector Percentile
Network Analysis
48 Degree Centrality
Ego Network (top connections)
White House (weight 56.0)PlocamiumAI (weight 48.0)United States (weight 43.0)HHS (weight 42.0)AstraZeneca (weight 32.0)Dr. (weight 28.0)WASHINGTON (weight 25.0)Robert F. Kennedy Jr. (weight 24.0) White HousePlocamiumAIUnited StatesHHSAstraZenecaDr.WASHINGTONRobert F. Kenned… FDA (degree 48) FDA
Centrality History
2026-06-17 2026-07-17 51 0 Degree Mentions
EntityWeight StatusFirst Seen
White House 56 STABLE
PlocamiumAI 48 NEW
United States 43 STABLE
HHS 42 STABLE
AstraZeneca 32 NEW
Dr. 28 NEW
WASHINGTON 25 STABLE
Robert F. Kennedy Jr. 24 NEW
Eli Lilly 19 NEW
RFK Jr. 18 NEW
CMS 17 STABLE
China 17 STABLE
Europe 16 STABLE
Americans 16 NEW
President 12 STABLE
Reuters 11 STABLE
CEO 10 STABLE
Bloomberg 10 STRENGTHENED
Trump administration 10 STABLE
AP 9 STABLE
Merck 9 STABLE
U.S. Department of Health and Human Services 9 NEW
Canada 8 STABLE
Supreme Court 8 STABLE
France 8 NEW
Senate 7 NEW
Nasdaq 7 STABLE
California 6 STABLE
Asia 6 STABLE
Donald Trump 6 STABLE
Article Coverage (1)
DateLaneTitle
2026-07-17 Healthcare M&A Pharmaceutical Makers Win Simpler Registration Rules While Foreign Suppliers Face New FDA Oversight

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-07-17 ← Intelligence Network